Literature DB >> 1824593

T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gamma delta + T cells.

O Janssen1, S Wesselborg, B Heckl-Ostreicher, K Pechhold, A Bender, S Schondelmaier, G Moldenhauer, D Kabelitz.   

Abstract

mAb directed against the TCR/CD3 complex activate resting T cells. However, TCR/CD3 signaling induces death by apoptosis in immature (CD4+CD8+) murine thymocytes and certain transformed leukemic T cell lines. Here we show that anti-TCR and anti-CD3 mAb induce growth arrest of cloned TCR-gamma delta + T cells in the presence of IL-2. In the absence of exogenous IL-2, however, the very same anti-TCR/CD3 mAb stimulated gamma delta (+)-clones to proliferation and IL-2 production. In the presence of exogenous IL-2, anti-TCR/CD3 mAb induced the degradation of DNA into oligosomal bands of approximately 200 bp length in cloned gamma delta + T cells. This pattern of DNA fragmentation is characteristic for the programmed cell death termed apoptosis. These results demonstrate that TCR/CD3 signaling can induce cell death in cloned gamma delta + T cells. In addition, this report is the first to show that apoptosis triggered by TCR/CD3 signaling is not restricted to CD4+CD8+ immature thymocytes and transformed leukemic T cell lines but can be also observed with IL-2-dependent normal (i.e., TCR-gamma delta +) T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824593

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections.

Authors:  M Wallace; A M Scharko; C D Pauza; P Fisch; K Imaoka; S Kawabata; K Fujihashi; H Kiyono; Y Tanaka; B R Bloom; M Malkovsky
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin.

Authors:  B A Leonard; P M Schlievert
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Kinetics of accumulation of gamma delta receptor-bearing T lymphocytes in mice infected with live mycobacteria.

Authors:  J P Griffin; K V Harshan; W K Born; I M Orme
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR.

Authors:  Huiyong Wei; Dan Huang; Xiaomin Lai; Meiling Chen; Weihua Zhong; Richard Wang; Zheng W Chen
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 5.  Gammadelta T cells as immune effectors against high-grade gliomas.

Authors:  Lawrence S Lamb
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells.

Authors:  Yoshihiro Michishita; Makoto Hirokawa; Yong-Mei Guo; Yukiko Abe; Jiajia Liu; Kumi Ubukawa; Naohito Fujishima; Masumi Fujishima; Tomoko Yoshioka; Yoshihiro Kameoka; Hirobumi Saito; Hiroyuki Tagawa; Naoto Takahashi; Kenichi Sawada
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

7.  Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.

Authors:  M A Alexander-Miller; G R Leggatt; A Sarin; J A Berzofsky
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 8.  Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.

Authors:  Richard D Lopez
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

9.  Monocytes control gamma/delta T-cell responses by a secreted product.

Authors:  A J Okragly; M Hanby-Flarida; C L Baldwin
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

10.  Polyclonal T cell elimination by prolonged immunostimulation in an experimental model.

Authors:  F Galdiero; M Galdiero; I Nuzzo; M Vitiello; C Bentivoglio; C Romano-Carratelli
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.